Percutaneous coronary revascularisation: is it ever worth what it costs?

Mark, Daniel B · Heart · 2007

editorial · Level V

Where this comes from

Abstract

“How could percutaneous coronary intervention without the risks and morbidities of heart surgery not be of benefit to patients? Hard experience teaches that such attractive “pathophysiological” simplifications are unreliable guides to practice and paradoxically may lead to worse rather than better treatment decisions” <i> See also article on page 1238 and viewpoint on page 1188</i>

Medical subject headings